"Executive Summary Secondary Hyperoxaluria Drug Market :
The global secondary hyperoxaluria drug market size was valued at USD 152.4 million in 2024 and is expected to reach USD 256.61 million by 2032, at a CAGR of 6.73% during the forecast period
The market growth is largely fueled by the increasing prevalence of primary and secondary...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek